Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-04, Stock:JNJ, The news for the past five days is as follows:
2018-03-27: NEWS1: 3 Dividend Stocks Ideal for Retirees.NEWS2: 3 Dividend Stocks Ideal for Retirees.NEWS3: Platinum Equity lines up US$1.9 billion of debt for J&J diabetes care unit bid.NEWS4: 10 Biggest Product Recalls of All Time.NEWS5: 10 Biggest Product Recalls of All Time.NEWS6: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 - JNJ.NEWS7: Platinum Equity lines up US$1.9bn of debt for J&J diabetes care unit bid.NEWS8: NYSE trader: Don't expect crazy volatility due to end-of-quarter portfolio rebalancing—but Facebook could get dumped.NEWS9: Why Geron Corporation Stock Is Crashing Today.NEWS10: Commentary: How Facebook’s Response Ignited the Cambridge Analytica Scandal.NEWS11: 3 Chart Patterns That Suggest Prices Are Headed Lower.
2018-03-28: NEWS1: Top Research Reports for Johnson & Johnson, Intel and Procter & Gamble.NEWS2: Top Research Reports for Johnson & Johnson, Intel and Procter & Gamble.NEWS3: Top Research Reports for Johnson & Johnson, Intel and Procter & Gamble.NEWS4: How Did Novartis Perform in 4Q17 and Full-Year 2017?.NEWS5: 3 Dow Stocks to Buy Amid Tech Selloff.NEWS6: 3 Dow Stocks to Buy Amid Tech Selloff.NEWS7: FDA working on a "dozen" policies to boost copycat biotech drugs.NEWS8: AbbVie a Top Ranked SAFE Dividend Stock With 4.2% Yield (ABBV).NEWS9: AbbVie a Top Ranked SAFE Dividend Stock With 4.2% Yield (ABBV).NEWS10: In Battle To Cut Drug Prices, Outcome-Based Pricing Carries Big Risks For Biopharma.NEWS11: Big Pharma&apos;s billion-dollar scramble to invest in start-ups to fuel innovation.NEWS12: Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation.
2018-03-29: NEWS1: Geron Corp. Skyrocketed and AbbVie Inc. Crashed -- Are These Stocks Buys?.NEWS2: Arkansas sues opioid manufacturers for roles in epidemic.NEWS3: JNJ INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018.NEWS4: Tackle Market Uncertainty With These 3 Quality Dividend ETFs.NEWS5: Tackle Market Uncertainty With These 3 Quality Dividend ETFs.NEWS6: Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Johnson & Johnson Investors (JNJ).NEWS7: Eli Lilly’s Segment-by-Segment Performance in 4Q17.NEWS8: What’s Merck’s Valuation in March 2018?.NEWS9: How Is Novartis’s Cosentyx Positioned after 4Q17?.NEWS10: A Look at Bristol-Myers Squibb’s Eliquis in 4Q17.NEWS11: What Analysts Recommend for Merck in March 2018.NEWS12: Eli Lilly and Company’s Valuation in March 2018.NEWS13: The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton.NEWS14: The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton.NEWS15: These 3 Biotech Stocks Are Soaring, but Are They Buys Now?.NEWS16: Incyte Could Have a Problem (or 2!) on Its Hands.NEWS17: How Merck Stock Has Performed Recently.NEWS18: The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton.
2018-04-02: NEWS1: U.S. Justice Department seeks role in opioid settlement talks.NEWS2: Why I Won&apos;t Buy Ethereum.NEWS3: DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson and Encourages Investors to Contact The Firm.NEWS4: Why Geron Corporation Stock Is Falling Today.NEWS5: Why Geron Corporation Stock Is Falling Today.NEWS6: EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 - JNJ.NEWS7: How an ill-advised tweet became a nightmare for a Fox News show.NEWS8: iShares Russell 1000 ETF Experiences Big Outflow.NEWS9: iShares Russell 1000 ETF Experiences Big Outflow.NEWS10: Why Geron Corporation Stock Is Falling Today.NEWS11: Shire's Stock Continues to Rise as Takeda Sets Eyes On it.NEWS12: Shire's Stock Continues to Rise as Takeda Sets Eyes On it.NEWS13: How Novartis’s Alcon Performed in 4Q17 and Fiscal 2017.NEWS14: How Novartis’s Alcon Performed in 4Q17 and Fiscal 2017.NEWS15: How Eli Lilly’s Neuroscience Products Performed in 4Q17.NEWS16: How Eli Lilly’s Neuroscience Products Performed in 4Q17.NEWS17: How Did Sandoz Perform in 4Q17 and Fiscal 2017?.NEWS18: How Did Sandoz Perform in 4Q17 and Fiscal 2017?.NEWS19: Are Short-Sellers Right About Geron Corporation?.NEWS20: Are Short-Sellers Right About Geron Corporation?.NEWS21: Are Short-Sellers Right About Geron Corporation?.
2018-04-03: NEWS1: Pfizer Reportedly In Talks With P&G On Consumer Business Sale.NEWS2: Pfizer Reportedly In Talks With P&G On Consumer Business Sale.NEWS3: The 10 Best Stocks to Buy for April.NEWS4: The 10 Best Stocks to Buy for April.NEWS5: IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson And Reminds Investors To Contact The Firm.NEWS6: Johnson & Johnson Stock on March 29, 2018.NEWS7: Markets Right Now: Late rally sends US stock indexes higher.NEWS8: The Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018 (JNJ).NEWS9: Markets Right Now: Stocks move solidly higher on Wall Street.NEWS10: Markets Right Now: Stocks move solidly higher on Wall Street.NEWS11: Pfizer in talks with P&G for consumer health unit sale - CNBC.NEWS12: The brand boycott of Laura Ingraham’s Fox News show barely registers with consumers.NEWS13: The brand boycott of Laura Ingraham’s Fox News show barely registers with consumers.NEWS14: Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price: Sources.NEWS15: Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price: Sources.NEWS16: Pfizer in talks with P&G for consumer health unit sale - CNBC.NEWS17: What Analysts Recommend for Novartis in March 2018.NEWS18: What Analysts Recommend for Novartis in March 2018.NEWS19: Will These Drugs Reach Blockbuster Status?.NEWS20: Will These Drugs Reach Blockbuster Status?.NEWS21: April 9th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Johnson & Johnson (JNJ).

Answer: Rise